ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 760

Diagnosing SLE Arthritis with Dynamic Diffuse Optical Spectroscopy

George Danias1, Youngwan Kim2, Alessandro Marone3, Kayla Neville1, Andrea Frantz1, Teja Kapoor4, Laura Geraldino-Pardilla1, Ioannis Kymissis2, Andreas Hielscher2,3,5 and Anca Askanase1, 1Rheumatology, Columbia University Medical Center, New York, NY, 2Electrical Engineering, Columbia University, New York, NY, 3Biomedical Engineering, Columbia University, New York, NY, 4Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 5Radiology, Columbia University Medical Center, New York, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Arthritis, Computed tomography (CT), Imaging, inflammation and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, October 21, 2018

Title: Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: SLE arthritis is difficult to evaluate because of the sometimes-evanescent nature of the symptoms and limitations of physical exams and imaging studies. Dynamic diffuse optical spectroscopy (dDOS) can be used to assess changes in light absorption through tissues during transient venous occlusion. The optical signal reflects changes in blood perfusion and has diagnostic value in rheumatoid arthritis. The current study explored the use of dDOS in SLE arthritis.

Methods: 11 SLE patients (ACR criteria) with active arthritis and 4 controls were evaluated. A dDOS sensor module was developed (Fig. 1).  Hemodynamic effects were obtained by inflating a BP cuff to 40 mmHg x 60 seconds. Light at 3 wavelengths (lambda = 530, 655, 940nm) was used to illuminate joints at 8 different points. Transmitted light intensities were measured with Si-photodetectors at 8 other positions (total 8x8x3=192 signal traces). Swollen, tender and healthy joints were examined by the same assessor.

Results: SLE patients and normal controls dDOS data were available for analysis from 66 and 24 proximal interphalangeal (PIP) joints, respectively (PIPs 2-4). Best results were obtained at 530 nm with cuff inflation at 40 mmHg. A representative measurement of 3 SLE arthritis and 3 normal joints is shown in Fig. 2, highlighting differences in rise and plateau time. Given the pronounced effects at lambda = 530nm, we speculate that altered vessel physiology paired with already-increased blood pooling in the affected inflamed joints resulted in quicker increase in light absorption (rise time) that is maintained longer (plateau time) compared to normal joints. The AUC for dDOS was consistent with excellent discrimination, AUC = 0.8639, sensitivity = 76.19, specificity = 88.57 (Fig. 3).

Conclusion: dDOS can evaluate SLE arthritis with high sensitivity and specificity. Rise and plateau time of the optical traces correlate strongly with swollen and tender joint count. The advantages of dDOS are non-invasiveness, objectivity (eliminates inter-rater variability and operator dependency), low cost, and high speed of performance (~5 min per area of scanning) compared to US and MRI. dDOS has the potential to bring much-needed objectivity to the quantification of SLE arthritis.


Disclosure: G. Danias, None; Y. Kim, None; A. Marone, None; K. Neville, None; A. Frantz, None; T. Kapoor, None; L. Geraldino-Pardilla, None; I. Kymissis, None; A. Hielscher, None; A. Askanase, None.

To cite this abstract in AMA style:

Danias G, Kim Y, Marone A, Neville K, Frantz A, Kapoor T, Geraldino-Pardilla L, Kymissis I, Hielscher A, Askanase A. Diagnosing SLE Arthritis with Dynamic Diffuse Optical Spectroscopy [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/diagnosing-sle-arthritis-with-dynamic-diffuse-optical-spectroscopy/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diagnosing-sle-arthritis-with-dynamic-diffuse-optical-spectroscopy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology